Based on the discovery of a novel class of neuroplasticity-promoting therapeutics known as psychoplastogens, Delix is building a company to find solutions for CNS-related diseases.. Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.